{"id":256301,"date":"2014-02-07T17:49:12","date_gmt":"2014-02-07T22:49:12","guid":{"rendered":"http:\/\/www.eugenesis.com\/nanomedicine-market-is-expected-to-reach-usd-177-60-billion-in-2019\/"},"modified":"2014-02-07T17:49:12","modified_gmt":"2014-02-07T22:49:12","slug":"nanomedicine-market-is-expected-to-reach-usd-177-60-billion-in-2019","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/nanomedicine-2\/nanomedicine-market-is-expected-to-reach-usd-177-60-billion-in-2019.php","title":{"rendered":"Nanomedicine Market is Expected to Reach USD 177.60 Billion in 2019"},"content":{"rendered":"<p><p>    Albany, NY (PRWEB) February 07, 2014  <\/p>\n<p>    According to a new market report published by Transparency    Market Research \"Nanomedicine Market (Neurology,    Cardiovascular, Anti-inflammatory, Anti-infective, and Oncology    Applications) - Global Industry Analysis, Size, Share,Growth,    Trends and Forecast, 2013 - 2019,\" the market for nanomedicine    was valued at USD 78.54 billion in 2012 and is expected to    reach a value of USD 177.60 billion in 2019, growing at a CAGR    of 12.3% from 2013 to 2019.  <\/p>\n<p>    Browse the full report with complete TOC at <a href=\"http:\/\/www.transparencymarketresearch.com\/nanomedicine-market.html\" rel=\"nofollow\">http:\/\/www.transparencymarketresearch.com\/nanomedicine-market.html<\/a>  <\/p>\n<p>    The advent of new applications and technology in the field of    nanomedicine will be one of the major growth factors for the    global nanomedicine market. In addition, increase of funding    aimed at boosting the research activities pertaining to    nanomedicine by the government as well as private institutions    will expedite the process of commercialization of new products    and hence will drive the market. Other driving factors include    rising base of geriatric population, presence of high unmet    medical needs and rising worldwide incidences of chronic    diseases.  <\/p>\n<p>    The global nanomedicine market by applications was dominated by    the oncology market with a market share of approximately 38.0%    in 2012 on account of the presence of high number of    commercialized products in this segment. Development of    nanomedicine products enabling drugs crossing blood brain    barrier and targeting the tumor in brain and at other sites in    the body will prove to be a significant future growth driver    for this market.  <\/p>\n<p>    Related Report: Gastrointestinal Endoscopic Devices Market    <a href=\"http:\/\/www.transparencymarketresearch.com\/gastrointestinal-endoscopic-devices.html\" rel=\"nofollow\">http:\/\/www.transparencymarketresearch.com\/gastrointestinal-endoscopic-devices.html<\/a>  <\/p>\n<p>    However, the global cardiovascular market for nanomedicine is    the fastest growing application segment. Factors such as the    presence of large patient prevalence coupled with rising demand    for nanotechnology enabled drugs and devices catering to this    segment, attribute to its high growth rate.  <\/p>\n<p>    North America dominated the market in 2012 and is expected to    maintain its market position till 2019. However,    theAsia-Pacific market is estimated to grow at a faster pace    (CAGR of 14.6% from 2013 to 2019).Europe is expected to grow at    a relatively higher rate compared to North America owing to    constantly improving regulatory framework and the presence of    an extensive product pipeline portfolio.  <\/p>\n<p>    Some of the key players in the global nanomedicine    market include GE Healthcare, Merck & Co Inc., Abbott    Laboratories, Pfizer Inc., Nanosphere Inc., Mallinckrodt plc,    Teva Pharmaceutical Industries Ltd., Sigma-Tau Pharmaceuticals    Inc., Celgene Corporation, Novavax, Inc.; Life Technologies,    MagArray, Inc., Gilead Sciences Inc. and others.  <\/p>\n<p>    Blog: <a href=\"http:\/\/www.tmrblog.com\/\" rel=\"nofollow\">http:\/\/www.tmrblog.com\/<\/a>    Blog: <a href=\"http:\/\/www.culrav.org\/pr\/author\/tmrrelease\" rel=\"nofollow\">http:\/\/www.culrav.org\/pr\/author\/tmrrelease<\/a>  <\/p>\n<p><!-- Auto Generated --><\/p>\n<p>Read more from the original source:<br \/>\n<a target=\"_blank\" href=\"http:\/\/www.prweb.com\/releases\/2014\/02\/prweb11564497.htm\" title=\"Nanomedicine Market is Expected to Reach USD 177.60 Billion in 2019\">Nanomedicine Market is Expected to Reach USD 177.60 Billion in 2019<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> Albany, NY (PRWEB) February 07, 2014 According to a new market report published by Transparency Market Research \"Nanomedicine Market (Neurology, Cardiovascular, Anti-inflammatory, Anti-infective, and Oncology Applications) - Global Industry Analysis, Size, Share,Growth, Trends and Forecast, 2013 - 2019,\" the market for nanomedicine was valued at USD 78.54 billion in 2012 and is expected to reach a value of USD 177.60 billion in 2019, growing at a CAGR of 12.3% from 2013 to 2019. Browse the full report with complete TOC at <a href=\"http:\/\/www.transparencymarketresearch.com\/nanomedicine-market.html\" rel=\"nofollow\">http:\/\/www.transparencymarketresearch.com\/nanomedicine-market.html<\/a> The advent of new applications and technology in the field of nanomedicine will be one of the major growth factors for the global nanomedicine market. In addition, increase of funding aimed at boosting the research activities pertaining to nanomedicine by the government as well as private institutions will expedite the process of commercialization of new products and hence will drive the market <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/nanomedicine-2\/nanomedicine-market-is-expected-to-reach-usd-177-60-billion-in-2019.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":57,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[577779],"tags":[],"class_list":["post-256301","post","type-post","status-publish","format-standard","hentry","category-nanomedicine-2"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/256301"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/57"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=256301"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/256301\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=256301"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=256301"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=256301"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}